1|Page
ACRP CP FINAL EXAM NEWEST ACTUAL EXAM
COMPLETE 150 QUESTIONS AND 100%CORRECT
DETAILED ANSWERS 2025/2026 (VERIFIED
ANSWERS) |ALREADY GRADED A+
treatment effect - ANSWER-An effect attributed to a
treatment in a clinical trial. In most clinical trials the
treatment effect of interest is a comparison (or contrast) of
two or more treatments.
Surrogate Variable - ANSWER-A variable that provides an
indirect measurement of effect in situations where direct
measurement of clinical effect is not feasible or practical.
Superiority Trial - ANSWER-A trial with the primary
objective of showing that the response to the
,2|Page
investigational product is superior to a comparative agent
(active or placebo control).
Statistical Analysis Plan - ANSWER-Document that
contains a more technical and detailed elaboration of the
principal features of the analysis described in the protocol,
and includes detailed procedures for executing the
statistical analysis of the primary and secondary variables
and other data.
Tolerability - ANSWER-Represents the degree to which
overt adverse effects can be tolerated by the subject.
,3|Page
Product Safety - ANSWER-The medical risks to a subject,
usually assessed in a clinical trial by laboratory tests, vital
signs, clinical adverse events, and other safety tests.
Per Protocol Set - ANSWER-A set of data generated by
the subset of subjects who complied with the protocol
sufficiently to ensure that these data would be likely to
exhibit the effects of treatment, according to the underlying
scientific model. Compliance covers such considerations
as exposure to treatment, availability of measurements,
and absence of major protocol deviations.
Preferred Term - ANSWER-The level of grouping of
included terms typically used in reporting frequency of
occurance.
, 4|Page
Included Term - ANSWER-The lowest level of dictionary
term to which the investigator description is coded.
Non-inferiority Trial - ANSWER-A trial with the primary
objective of showing that the response to the
investigational product is not clinically inferior to a
comparative agent (active or placebo control).
Multicenter Trial - ANSWER-A clinical trial conducted
according to a single protocol but at more than one site,
and therefore, carried out by more than one investigator.
ACRP CP FINAL EXAM NEWEST ACTUAL EXAM
COMPLETE 150 QUESTIONS AND 100%CORRECT
DETAILED ANSWERS 2025/2026 (VERIFIED
ANSWERS) |ALREADY GRADED A+
treatment effect - ANSWER-An effect attributed to a
treatment in a clinical trial. In most clinical trials the
treatment effect of interest is a comparison (or contrast) of
two or more treatments.
Surrogate Variable - ANSWER-A variable that provides an
indirect measurement of effect in situations where direct
measurement of clinical effect is not feasible or practical.
Superiority Trial - ANSWER-A trial with the primary
objective of showing that the response to the
,2|Page
investigational product is superior to a comparative agent
(active or placebo control).
Statistical Analysis Plan - ANSWER-Document that
contains a more technical and detailed elaboration of the
principal features of the analysis described in the protocol,
and includes detailed procedures for executing the
statistical analysis of the primary and secondary variables
and other data.
Tolerability - ANSWER-Represents the degree to which
overt adverse effects can be tolerated by the subject.
,3|Page
Product Safety - ANSWER-The medical risks to a subject,
usually assessed in a clinical trial by laboratory tests, vital
signs, clinical adverse events, and other safety tests.
Per Protocol Set - ANSWER-A set of data generated by
the subset of subjects who complied with the protocol
sufficiently to ensure that these data would be likely to
exhibit the effects of treatment, according to the underlying
scientific model. Compliance covers such considerations
as exposure to treatment, availability of measurements,
and absence of major protocol deviations.
Preferred Term - ANSWER-The level of grouping of
included terms typically used in reporting frequency of
occurance.
, 4|Page
Included Term - ANSWER-The lowest level of dictionary
term to which the investigator description is coded.
Non-inferiority Trial - ANSWER-A trial with the primary
objective of showing that the response to the
investigational product is not clinically inferior to a
comparative agent (active or placebo control).
Multicenter Trial - ANSWER-A clinical trial conducted
according to a single protocol but at more than one site,
and therefore, carried out by more than one investigator.
